Clinical Trial Update: To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating JLP-2002 for efficacy and safety in overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• JLP-2002

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED